BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

798 related articles for article (PubMed ID: 30835879)

  • 1. Cross-national patterns of substance use disorder treatment and associations with mental disorder comorbidity in the WHO World Mental Health Surveys.
    Harris MG; Bharat C; Glantz MD; Sampson NA; Al-Hamzawi A; Alonso J; Bruffaerts R; Caldas de Almeida JM; Cia AH; de Girolamo G; Florescu S; Gureje O; Haro JM; Hinkov H; Karam EG; Karam G; Lee S; Lépine JP; Levinson D; Makanjuola V; McGrath J; Mneimneh Z; Navarro-Mateu F; Piazza M; Posada-Villa J; Rapsey C; Tachimori H; Ten Have M; Torres Y; Viana MC; Chatterji S; Zaslavsky AM; Kessler RC; Degenhardt L;
    Addiction; 2019 Aug; 114(8):1446-1459. PubMed ID: 30835879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concordance between the diagnostic guidelines for alcohol and cannabis use disorders in the draft ICD-11 and other classification systems: analysis of data from the WHO's World Mental Health Surveys.
    Degenhardt L; Bharat C; Bruno R; Glantz MD; Sampson NA; Lago L; Aguilar-Gaxiola S; Alonso J; Andrade LH; Bunting B; Caldas-de-Almeida JM; Cia AH; Gureje O; Karam EG; Khalaf M; McGrath JJ; Moskalewicz J; Lee S; Mneimneh Z; Navarro-Mateu F; Sasu CC; Scott K; Torres Y; Poznyak V; Chatterji S; Kessler RC;
    Addiction; 2019 Mar; 114(3):534-552. PubMed ID: 30370636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding mental health treatment in persons without mental diagnoses: results from the National Comorbidity Survey Replication.
    Druss BG; Wang PS; Sampson NA; Olfson M; Pincus HA; Wells KB; Kessler RC
    Arch Gen Psychiatry; 2007 Oct; 64(10):1196-203. PubMed ID: 17909132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences among major depressive disorder with and without co-occurring substance use disorders and substance-induced depressive disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
    Blanco C; Alegría AA; Liu SM; Secades-Villa R; Sugaya L; Davies C; Nunes EV
    J Clin Psychiatry; 2012 Jun; 73(6):865-73. PubMed ID: 22480900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of co-occurring substance use on 6 month outcomes for young people seeking mental health treatment.
    Baker KD; Lubman DI; Cosgrave EM; Killackey EJ; Yuen HP; Hides L; Baksheev GN; Buckby JA; Yung AR
    Aust N Z J Psychiatry; 2007 Nov; 41(11):896-902. PubMed ID: 17924242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substance use problems and associated psychiatric symptoms among adolescents in primary care.
    Shrier LA; Harris SK; Kurland M; Knight JR
    Pediatrics; 2003 Jun; 111(6 Pt 1):e699-705. PubMed ID: 12777588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between parental mental illness and/or substance use disorder on adolescent substance use disorder: Results from a nationally representative survey.
    Ali MM; Dean D; Hedden SL
    Addict Behav; 2016 Aug; 59():35-41. PubMed ID: 27070095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comorbid substance and mental disorders among rural Americans: results from the National Comorbidity Survey.
    Simmons LA; Havens JR
    J Affect Disord; 2007 Apr; 99(1-3):265-71. PubMed ID: 16978706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and correlates of alcohol and other substance use disorders in young adulthood: A population-based study.
    Latvala A; Tuulio-Henriksson A; Perälä J; Saarni SI; Aalto-Setälä T; Aro H; Korhonen T; Koskinen S; Lönnqvist J; Kaprio J; Suvisaari J
    BMC Psychiatry; 2009 Nov; 9():73. PubMed ID: 19925643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Cohort and Individual Substance Use With Risk of Transitioning to Drug Use, Drug Use Disorder, and Remission From Disorder: Findings From the World Mental Health Surveys.
    Degenhardt L; Bharat C; Glantz MD; Sampson NA; Al-Hamzawi A; Alonso J; Andrade LH; Bunting B; Cia A; de Girolamo G; De Jonge P; Demyttenaere K; Gureje O; Haro JM; Harris MG; He Y; Hinkov H; Karam AN; Karam EG; Kiejna A; Kovess-Masfety V; Lasebikan V; Lee S; Levinson D; Medina-Mora ME; Mneimneh Z; Navarro-Mateu F; Piazza M; Posada-Villa J; Scott K; Stein DJ; Tachimori H; Tintle N; Torres Y; Kessler RC;
    JAMA Psychiatry; 2019 Jul; 76(7):708-720. PubMed ID: 30865282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the course of substance use disorders among individuals with and without generalized anxiety disorder in a nationally representative sample.
    Magidson JF; Liu SM; Lejuez CW; Blanco C
    J Psychiatr Res; 2012 May; 46(5):659-66. PubMed ID: 22444600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probability and predictors of treatment-seeking for substance use disorders in the U.S.
    Blanco C; Iza M; Rodríguez-Fernández JM; Baca-García E; Wang S; Olfson M
    Drug Alcohol Depend; 2015 Apr; 149():136-44. PubMed ID: 25725934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substance use disorders comorbid with mood and anxiety disorders in the Australian general population.
    Prior K; Mills K; Ross J; Teesson M
    Drug Alcohol Rev; 2017 May; 36(3):317-324. PubMed ID: 27324816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary and secondary substance misusers: do they differ in substance-induced and substance-independent mental disorders?
    Bakken K; Landheim AS; Vaglum P
    Alcohol Alcohol; 2003; 38(1):54-9. PubMed ID: 12554609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substance Use Disorders Among US Adult Cancer Survivors.
    Jones KF; Osazuwa-Peters OL; Des Marais A; Merlin JS; Check DK
    JAMA Oncol; 2024 Mar; 10(3):384-389. PubMed ID: 38206609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent use of emergency departments for mental and substance use disorders.
    Urbanoski K; Cheng J; Rehm J; Kurdyak P
    Emerg Med J; 2018 Apr; 35(4):220-225. PubMed ID: 29311114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Risk of Alcohol-Impaired Driving in Adults With Comorbid Alcohol and Substance Use Disorders in the U.S. Population.
    Roberts W; Moore KE; Pittman BP; Fillmore MT; McKee SA
    J Stud Alcohol Drugs; 2019 Jan; 80(1):114-119. PubMed ID: 30807283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comorbid mental disorders in substance users from a single catchment area--a clinical study.
    Langås AM; Malt UF; Opjordsmoen S
    BMC Psychiatry; 2011 Feb; 11():25. PubMed ID: 21314980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contraceptive adherence among women Veterans with mental illness and substance use disorder.
    Callegari LS; Zhao X; Nelson KM; Borrero S
    Contraception; 2015 May; 91(5):386-92. PubMed ID: 25636807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lifetime and 12-month prevalence, severity and unmet need for treatment of common mental disorders in Japan: results from the final dataset of World Mental Health Japan Survey.
    Ishikawa H; Kawakami N; Kessler RC;
    Epidemiol Psychiatr Sci; 2016 Jun; 25(3):217-29. PubMed ID: 26148821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.